Frequencies for first 10,000 rows of indi_pt variable in indi2018q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- Abdominal discomfort | 17 0.17 0.17 Abdominal hernia | 1 0.01 0.18 Abdominal pain | 16 0.16 0.34 Abdominal pain upper | 8 0.08 0.42 Abnormal behaviour | 2 0.02 0.44 Abortion induced | 5 0.05 0.49 Abortion threatened | 1 0.01 0.50 Acarodermatitis | 1 0.01 0.51 Accidental exposure to product | 1 0.01 0.52 Acne | 4 0.04 0.56 Acquired immunodeficiency syndrome | 4 0.04 0.60 Acral overgrowth | 2 0.02 0.62 Acromegaly | 12 0.12 0.74 Acute graft versus host disease | 2 0.02 0.76 Acute lymphocytic leukaemia | 39 0.39 1.15 Acute myeloid leukaemia | 11 0.11 1.26 Acute pulmonary oedema | 1 0.01 1.27 Adenocarcinoma of colon | 4 0.04 1.31 Adenoma benign | 2 0.02 1.33 Adjuvant therapy | 1 0.01 1.34 Adrenal insufficiency | 1 0.01 1.35 Adverse drug reaction | 2 0.02 1.37 Affective disorder | 6 0.06 1.43 Age-related macular degeneration | 3 0.03 1.46 Agitation | 9 0.09 1.55 Alcoholic liver disease | 9 0.09 1.64 Alcoholism | 3 0.03 1.67 Allogenic bone marrow transplantation.. | 2 0.02 1.69 Anaemia | 8 0.08 1.77 Anaesthesia | 8 0.08 1.85 Anal candidiasis | 4 0.04 1.89 Analgesic therapy | 9 0.09 1.98 Aneurysm | 1 0.01 1.99 Anger | 2 0.02 2.01 Angina pectoris | 6 0.06 2.07 Angiogram | 1 0.01 2.08 Angiopathy | 1 0.01 2.09 Angiosarcoma | 1 0.01 2.10 Ankylosing spondylitis | 16 0.16 2.26 Antiallergic therapy | 1 0.01 2.27 Antibiotic level | 1 0.01 2.28 Antibiotic prophylaxis | 3 0.03 2.31 Antibiotic therapy | 7 0.07 2.38 Anticoagulant therapy | 14 0.14 2.52 Antidepressant therapy | 4 0.04 2.56 Antifungal prophylaxis | 5 0.05 2.61 Antifungal treatment | 2 0.02 2.63 Antiinflammatory therapy | 1 0.01 2.64 Antiplatelet therapy | 2 0.02 2.66 Antiretroviral therapy | 7 0.07 2.73 Antiviral prophylaxis | 6 0.06 2.79 Antiviral treatment | 5 0.05 2.84 Anxiety | 74 0.74 3.58 Anxiety disorder | 8 0.08 3.66 Aortic dissection | 2 0.02 3.68 Aortic valve incompetence | 2 0.02 3.70 Aplastic anaemia | 5 0.05 3.75 Arrhythmia | 7 0.07 3.82 Arterial thrombosis | 1 0.01 3.83 Arteritis | 1 0.01 3.84 Arthralgia | 13 0.13 3.97 Arthritis | 24 0.24 4.21 Arthritis infective | 2 0.02 4.23 Arthropathy | 2 0.02 4.25 Arthropod bite | 1 0.01 4.26 Ascites | 2 0.02 4.28 Aspergillus infection | 2 0.02 4.30 Asthenia | 2 0.02 4.32 Asthma | 80 0.80 5.12 Asthmatic crisis | 1 0.01 5.13 Astrocytoma, low grade | 1 0.01 5.14 Atherosclerosis prophylaxis | 2 0.02 5.16 Atrial fibrillation | 59 0.59 5.75 Attention deficit/hyperactivity disor.. | 14 0.14 5.89 Atypical haemolytic uraemic syndrome | 2 0.02 5.91 Auriculotemporal syndrome | 1 0.01 5.92 Autism spectrum disorder | 6 0.06 5.98 Autoimmune disorder | 1 0.01 5.99 Autoimmune haemolytic anaemia | 2 0.02 6.01 Autoimmune hepatitis | 1 0.01 6.02 Autoimmune thyroiditis | 1 0.01 6.03 Autonomic neuropathy | 1 0.01 6.04 B precursor type acute leukaemia | 7 0.07 6.11 B-cell lymphoma | 37 0.37 6.48 Back disorder | 1 0.01 6.49 Back pain | 58 0.58 7.07 Bacterial infection | 2 0.02 7.09 Bacterial pyelonephritis | 1 0.01 7.10 Bacterial vulvovaginitis | 1 0.01 7.11 Basal cell carcinoma | 1 0.01 7.12 Benign familial pemphigus | 1 0.01 7.13 Benign prostatic hyperplasia | 14 0.14 7.27 Bipolar I disorder | 1 0.01 7.28 Bipolar disorder | 25 0.25 7.53 Bladder adenocarcinoma stage unspecif.. | 3 0.03 7.56 Bladder cancer | 4 0.04 7.60 Bladder disorder | 2 0.02 7.62 Blast crisis in myelogenous leukaemia | 1 0.01 7.63 Blepharitis | 1 0.01 7.64 Blood bilirubin increased | 1 0.01 7.65 Blood caffeine | 1 0.01 7.66 Blood cholesterol | 7 0.07 7.73 Blood cholesterol abnormal | 16 0.16 7.89 Blood cholesterol increased | 35 0.35 8.24 Blood culture positive | 1 0.01 8.25 Blood disorder | 2 0.02 8.27 Blood magnesium decreased | 1 0.01 8.28 Blood parathyroid hormone increased | 1 0.01 8.29 Blood pressure abnormal | 22 0.22 8.51 Blood pressure increased | 6 0.06 8.57 Blood pressure management | 2 0.02 8.59 Blood pressure measurement | 5 0.05 8.64 Blood testosterone decreased | 3 0.03 8.67 Blood triglycerides | 2 0.02 8.69 Blood triglycerides increased | 2 0.02 8.71 Blood uric acid increased | 3 0.03 8.74 Body mass index increased | 1 0.01 8.75 Bone density decreased | 2 0.02 8.77 Bone development abnormal | 1 0.01 8.78 Bone disorder | 6 0.06 8.84 Bone lesion | 3 0.03 8.87 Bone loss | 2 0.02 8.89 Bone marrow conditioning regimen | 3 0.03 8.92 Bone marrow failure | 7 0.07 8.99 Bone marrow transplant | 3 0.03 9.02 Bone pain | 5 0.05 9.07 Brain neoplasm | 1 0.01 9.08 Brain neoplasm malignant | 1 0.01 9.09 Brain stem glioma | 1 0.01 9.10 Breakthrough pain | 4 0.04 9.14 Breast cancer | 76 0.76 9.90 Breast cancer female | 3 0.03 9.93 Breast cancer metastatic | 26 0.26 10.19 Breast cancer recurrent | 2 0.02 10.21 Breast cancer stage IV | 4 0.04 10.25 Bronchiectasis | 2 0.02 10.27 Bronchitis | 10 0.10 10.37 Bronchitis chronic | 8 0.08 10.45 Bronchopulmonary aspergillosis | 9 0.09 10.54 Brown-Sequard syndrome | 1 0.01 10.55 Burkitt's lymphoma | 15 0.15 10.70 Burning sensation | 6 0.06 10.76 Bursitis | 1 0.01 10.77 C-reactive protein increased | 1 0.01 10.78 Calcium deficiency | 3 0.03 10.81 Calculus urinary | 4 0.04 10.85 Cancer pain | 4 0.04 10.89 Candida infection | 4 0.04 10.93 Carcinoid syndrome | 1 0.01 10.94 Carcinoid tumour | 4 0.04 10.98 Cardiac discomfort | 1 0.01 10.99 Cardiac disorder | 53 0.53 11.52 Cardiac failure | 29 0.29 11.81 Cardiac failure chronic | 8 0.08 11.89 Cardiac failure congestive | 4 0.04 11.93 Cardiac operation | 1 0.01 11.94 Cardiomyopathy | 1 0.01 11.95 Cardiovascular disorder | 4 0.04 11.99 Carotid arteriosclerosis | 1 0.01 12.00 Cataplexy | 9 0.09 12.09 Cataract | 2 0.02 12.11 Cataract operation | 4 0.04 12.15 Cauda equina syndrome | 1 0.01 12.16 Cellulitis | 8 0.08 12.24 Central obesity | 1 0.01 12.25 Cerebral aspergillosis | 1 0.01 12.26 Cerebral infarction | 7 0.07 12.33 Cerebral oedema management | 1 0.01 12.34 Cerebral toxoplasmosis | 2 0.02 12.36 Cerebrovascular accident | 3 0.03 12.39 Cerebrovascular accident prophylaxis | 27 0.27 12.66 Cerebrovascular disorder | 2 0.02 12.68 Cervical radiculopathy | 1 0.01 12.69 Cervical spinal stenosis | 1 0.01 12.70 Cervix carcinoma | 5 0.05 12.75 Cervix carcinoma recurrent | 12 0.12 12.87 Chelation therapy | 1 0.01 12.88 Chemotherapy | 12 0.12 13.00 Chemotherapy multiple agents systemic | 1 0.01 13.01 Chest pain | 5 0.05 13.06 Chills | 1 0.01 13.07 Chlamydial infection | 3 0.03 13.10 Chloroma | 1 0.01 13.11 Cholangiocarcinoma | 1 0.01 13.12 Cholangitis | 1 0.01 13.13 Cholelithiasis | 1 0.01 13.14 Chondropathy | 2 0.02 13.16 Chorea | 2 0.02 13.18 Choroidal neovascularisation | 1 0.01 13.19 Chronic eosinophilic leukaemia | 1 0.01 13.20 Chronic gastritis | 6 0.06 13.26 Chronic hepatitis B | 1 0.01 13.27 Chronic hepatitis C | 11 0.11 13.38 Chronic infantile neurological cutane.. | 8 0.08 13.46 Chronic kidney disease | 11 0.11 13.57 Chronic lymphocytic leukaemia | 14 0.14 13.71 Chronic myeloid leukaemia | 132 1.32 15.03 Chronic obstructive pulmonary disease | 27 0.27 15.30 Chronic sinusitis | 2 0.02 15.32 Clostridium colitis | 1 0.01 15.33 Clostridium difficile colitis | 1 0.01 15.34 Coagulopathy | 1 0.01 15.35 Cognitive disorder | 1 0.01 15.36 Colitis | 1 0.01 15.37 Colitis ulcerative | 9 0.09 15.46 Colon cancer | 8 0.08 15.54 Colon cancer metastatic | 5 0.05 15.59 Colon cancer stage III | 6 0.06 15.65 Colorectal cancer | 22 0.22 15.87 Colorectal cancer metastatic | 25 0.25 16.12 Complex regional pain syndrome | 2 0.02 16.14 Congenital cystic kidney disease | 1 0.01 16.15 Congestive cardiomyopathy | 1 0.01 16.16 Conjunctivitis | 1 0.01 16.17 Constipation | 44 0.44 16.61 Contraception | 114 1.14 17.75 Cor pulmonale chronic | 1 0.01 17.76 Corneal disorder | 1 0.01 17.77 Coronary angioplasty | 1 0.01 17.78 Coronary artery bypass | 1 0.01 17.79 Coronary artery disease | 11 0.11 17.90 Coronary artery stenosis | 1 0.01 17.91 Cough | 10 0.10 18.01 Craniocerebral injury | 4 0.04 18.05 Craniopharyngioma | 1 0.01 18.06 Crohn's disease | 60 0.60 18.66 Crying | 2 0.02 18.68 Cryptococcosis | 1 0.01 18.69 Cushing's syndrome | 1 0.01 18.70 Cyst | 1 0.01 18.71 Cystic fibrosis | 4 0.04 18.75 Cystic fibrosis pancreatic | 2 0.02 18.77 Cystitis | 1 0.01 18.78 Cystitis interstitial | 3 0.03 18.81 Cystitis noninfective | 1 0.01 18.82 Cytomegalovirus infection | 1 0.01 18.83 Cytomegalovirus viraemia | 1 0.01 18.84 Deafness neurosensory | 2 0.02 18.86 Decreased appetite | 1 0.01 18.87 Deep vein thrombosis | 11 0.11 18.98 Delirium tremens | 1 0.01 18.99 Delusion | 1 0.01 19.00 Dementia | 5 0.05 19.05 Dementia Alzheimer's type | 17 0.17 19.22 Dental care | 1 0.01 19.23 Dental caries | 1 0.01 19.24 Dental disorder prophylaxis | 1 0.01 19.25 Depressed mood | 5 0.05 19.30 Depression | 168 1.68 20.98 Depressive symptom | 1 0.01 20.99 Dermal cyst | 1 0.01 21.00 Dermatitis | 1 0.01 21.01 Dermatitis allergic | 1 0.01 21.02 Dermatomyositis | 2 0.02 21.04 Dermatophytosis of nail | 3 0.03 21.07 Detoxification | 1 0.01 21.08 Device related sepsis | 1 0.01 21.09 Diabetes mellitus | 90 0.90 21.99 Diabetic foot | 1 0.01 22.00 Diabetic nephropathy | 1 0.01 22.01 Diabetic neuropathy | 17 0.17 22.18 Diabetic retinal oedema | 2 0.02 22.20 Dialysis | 1 0.01 22.21 Diarrhoea | 26 0.26 22.47 Diffuse large B-cell lymphoma | 11 0.11 22.58 Disseminated intravascular coagulation | 1 0.01 22.59 Disseminated tuberculosis | 3 0.03 22.62 Diuretic therapy | 7 0.07 22.69 Dizziness | 2 0.02 22.71 Drug abuse | 4 0.04 22.75 Drug dependence | 9 0.09 22.84 Drug dispensed to wrong patient | 1 0.01 22.85 Drug effect decreased | 1 0.01 22.86 Drug hypersensitivity | 1 0.01 22.87 Drug therapy | 11 0.11 22.98 Dry eye | 4 0.04 23.02 Dry mouth | 1 0.01 23.03 Dwarfism | 1 0.01 23.04 Dysbacteriosis | 1 0.01 23.05 Dyskinesia | 2 0.02 23.07 Dyslipidaemia | 9 0.09 23.16 Dyspepsia | 19 0.19 23.35 Dysphagia | 1 0.01 23.36 Dyspnoea | 8 0.08 23.44 Ear infection | 3 0.03 23.47 Eating disorder | 2 0.02 23.49 Eczema | 11 0.11 23.60 Ejection fraction | 1 0.01 23.61 Emphysema | 11 0.11 23.72 Encephalitis | 3 0.03 23.75 Endocarditis prophylaxis | 1 0.01 23.76 Endocarditis staphylococcal | 1 0.01 23.77 Endocrine ophthalmopathy | 2 0.02 23.79 Endotracheal intubation | 2 0.02 23.81 Enterococcal infection | 2 0.02 23.83 Enterococcal sepsis | 1 0.01 23.84 Enthesopathy | 1 0.01 23.85 Epilepsy | 37 0.37 24.22 Erectile dysfunction | 4 0.04 24.26 Eructation | 4 0.04 24.30 Erythema multiforme | 1 0.01 24.31 Essential hypertension | 12 0.12 24.43 Exposure during pregnancy | 1 0.01 24.44 External ear cellulitis | 1 0.01 24.45 Extrasystoles | 2 0.02 24.47 Eye disorder | 1 0.01 24.48 Fabry's disease | 13 0.13 24.61 Face oedema | 1 0.01 24.62 Facial paralysis | 2 0.02 24.64 Facial spasm | 1 0.01 24.65 Factor VIII deficiency | 1 0.01 24.66 Fallopian tube cancer | 4 0.04 24.70 Fatigue | 3 0.03 24.73 Febrile neutropenia | 3 0.03 24.76 Female sterilisation | 1 0.01 24.77 Femur fracture | 1 0.01 24.78 Fibromyalgia | 43 0.43 25.21 Flatulence | 4 0.04 25.25 Fluid replacement | 3 0.03 25.28 Fluid retention | 5 0.05 25.33 Focal dyscognitive seizures | 4 0.04 25.37 Foetal exposure during pregnancy | 10 0.10 25.47 Folate deficiency | 9 0.09 25.56 Full blood count decreased | 1 0.01 25.57 Fungal infection | 2 0.02 25.59 Fungal skin infection | 1 0.01 25.60 Furuncle | 2 0.02 25.62 Gait disturbance | 8 0.08 25.70 Gastric dilatation | 1 0.01 25.71 Gastric disorder | 5 0.05 25.76 Gastric ulcer | 10 0.10 25.86 Gastritis | 18 0.18 26.04 Gastritis prophylaxis | 8 0.08 26.12 Gastroduodenal ulcer | 2 0.02 26.14 Gastroenteritis | 1 0.01 26.15 Gastrointestinal angiodysplasia | 3 0.03 26.18 Gastrointestinal disorder | 5 0.05 26.23 Gastrointestinal disorder therapy | 4 0.04 26.27 Gastrointestinal haemorrhage | 3 0.03 26.30 Gastrointestinal hypomotility | 1 0.01 26.31 Gastrointestinal motility disorder | 1 0.01 26.32 Gastrointestinal stromal tumour | 17 0.17 26.49 Gastrooesophageal reflux disease | 70 0.70 27.19 Gaucher's disease | 5 0.05 27.24 Generalised anxiety disorder | 1 0.01 27.25 Gestational diabetes | 2 0.02 27.27 Giardiasis | 1 0.01 27.28 Gigantism | 1 0.01 27.29 Glaucoma | 20 0.20 27.49 Glaucoma surgery | 1 0.01 27.50 Glomerulonephritis membranoproliferat.. | 1 0.01 27.51 Glomerulonephritis membranous | 3 0.03 27.54 Glucose tolerance impaired | 1 0.01 27.55 Glycogen storage disease type II | 5 0.05 27.60 Glycosylated haemoglobin increased | 1 0.01 27.61 Goitre | 3 0.03 27.64 Gonococcal infection | 1 0.01 27.65 Gout | 9 0.09 27.74 Graft versus host disease in gastroin.. | 1 0.01 27.75 Grief reaction | 3 0.03 27.78 Growth hormone deficiency | 9 0.09 27.87 Growth hormone-producing pituitary tu.. | 1 0.01 27.88 Growth retardation | 1 0.01 27.89 Guillain-Barre syndrome | 2 0.02 27.91 HER-2 positive breast cancer | 17 0.17 28.08 HIV infection | 95 0.95 29.03 HIV test positive | 9 0.09 29.12 Haemolytic uraemic syndrome | 1 0.01 29.13 Haemophagocytic lymphohistiocytosis | 3 0.03 29.16 Haemophilia | 1 0.01 29.17 Haemorrhage | 1 0.01 29.18 Haemorrhoids | 2 0.02 29.20 Hallucination | 2 0.02 29.22 Hallucination, auditory | 2 0.02 29.24 Headache | 31 0.31 29.55 Heart rate abnormal | 1 0.01 29.56 Heart rate increased | 1 0.01 29.57 Heart rate irregular | 2 0.02 29.59 Heart valve stenosis | 2 0.02 29.61 Hepatic cancer metastatic | 1 0.01 29.62 Hepatic cirrhosis | 2 0.02 29.64 Hepatic cyst infection | 1 0.01 29.65 Hepatic failure | 1 0.01 29.66 Hepatic function abnormal | 1 0.01 29.67 Hepatitis B | 3 0.03 29.70 Hepatitis C | 20 0.20 29.90 Hepato-lenticular degeneration | 4 0.04 29.94 Hernia | 4 0.04 29.98 Herpes dermatitis | 2 0.02 30.00 Herpes ophthalmic | 1 0.01 30.01 Herpes virus infection | 1 0.01 30.02 Herpes zoster | 9 0.09 30.11 Hiatus hernia | 4 0.04 30.15 High density lipoprotein decreased | 1 0.01 30.16 Hodgkin's disease | 8 0.08 30.24 Hormone replacement therapy | 5 0.05 30.29 Hot flush | 3 0.03 30.32 Huntington's disease | 8 0.08 30.40 Hydronephrosis | 4 0.04 30.44 Hyperammonaemia | 1 0.01 30.45 Hyperbilirubinaemia | 1 0.01 30.46 Hypercalcaemia | 2 0.02 30.48 Hypercalcaemia of malignancy | 1 0.01 30.49 Hyperchlorhydria | 2 0.02 30.51 Hypercholesterolaemia | 34 0.34 30.85 Hypercoagulation | 2 0.02 30.87 Hyperglycaemia | 4 0.04 30.91 Hyperinsulinism | 1 0.01 30.92 Hyperkalaemia | 1 0.01 30.93 Hyperlipidaemia | 16 0.16 31.09 Hyperparathyroidism | 1 0.01 31.10 Hyperphosphataemia | 6 0.06 31.16 Hyperprolactinaemia | 1 0.01 31.17 Hyperpyrexia | 1 0.01 31.18 Hypersensitivity | 22 0.22 31.40 Hypersomnia | 1 0.01 31.41 Hypertension | 398 3.98 35.39 Hyperthyroidism | 3 0.03 35.42 Hypertonic bladder | 3 0.03 35.45 Hypertrophic cardiomyopathy | 1 0.01 35.46 Hyperuricaemia | 13 0.13 35.59 Hypnotherapy | 1 0.01 35.60 Hypoaesthesia | 4 0.04 35.64 Hypoalbuminaemia | 1 0.01 35.65 Hypocalcaemia | 1 0.01 35.66 Hypochromic anaemia | 1 0.01 35.67 Hypokalaemia | 8 0.08 35.75 Hypomagnesaemia | 1 0.01 35.76 Hypopituitarism | 4 0.04 35.80 Hypotension | 9 0.09 35.89 Hypothalamo-pituitary disorder | 1 0.01 35.90 Hypothyroidism | 42 0.42 36.32 Hypovitaminosis | 4 0.04 36.36 Hysterectomy | 1 0.01 36.37 Ichthyosis | 1 0.01 36.38 IgA nephropathy | 1 0.01 36.39 Ill-defined disorder | 27 0.27 36.66 Immune thrombocytopenic purpura | 14 0.14 36.80 Immunisation | 26 0.26 37.06 Immunosuppressant drug therapy | 12 0.12 37.18 Immunosuppression | 4 0.04 37.22 Impaired gastric emptying | 1 0.01 37.23 Incontinence | 2 0.02 37.25 Infantile spasms | 1 0.01 37.26 Infarction | 1 0.01 37.27 Infection | 22 0.22 37.49 Infection prophylaxis | 13 0.13 37.62 Inflammation | 1 0.01 37.63 Inflammatory bowel disease | 1 0.01 37.64 Inflammatory carcinoma of breast stag.. | 9 0.09 37.73 Influenza | 6 0.06 37.79 Influenza like illness | 1 0.01 37.80 Initial insomnia | 1 0.01 37.81 Insomnia | 50 0.50 38.31 Intentional overdose | 3 0.03 38.34 Intentional product misuse | 2 0.02 38.36 Intentional self-injury | 2 0.02 38.38 Interstitial lung disease | 1 0.01 38.39 Intertrigo | 1 0.01 38.40 Intervertebral disc compression | 1 0.01 38.41 Intervertebral disc degeneration | 2 0.02 38.43 Intervertebral disc protrusion | 6 0.06 38.49 Intestinal fistula | 1 0.01 38.50 Intraductal proliferative breast lesion | 2 0.02 38.52 Intraocular pressure increased | 1 0.01 38.53 Invasive ductal breast carcinoma | 7 0.07 38.60 Iron deficiency | 1 0.01 38.61 Iron deficiency anaemia | 8 0.08 38.69 Iron overload | 11 0.11 38.80 Ischaemic cardiomyopathy | 3 0.03 38.83 Ischaemic heart disease prophylaxis | 4 0.04 38.87 Ischaemic stroke | 3 0.03 38.90 Joint injury | 2 0.02 38.92 Joint swelling | 1 0.01 38.93 Juvenile idiopathic arthritis | 13 0.13 39.06 Keratosis follicular | 2 0.02 39.08 Kidney transplant rejection | 1 0.01 39.09 Labour pain | 1 0.01 39.10 Leukaemia | 2 0.02 39.12 Limb discomfort | 1 0.01 39.13 Liver disorder | 3 0.03 39.16 Liver transplant | 5 0.05 39.21 Liver transplant rejection | 1 0.01 39.22 Local anaesthesia | 1 0.01 39.23 Low density lipoprotein | 2 0.02 39.25 Low density lipoprotein increased | 3 0.03 39.28 Lower respiratory tract infection | 4 0.04 39.32 Lumbar radiculopathy | 3 0.03 39.35 Lung adenocarcinoma | 2 0.02 39.37 Lung adenocarcinoma stage IV | 1 0.01 39.38 Lung cancer metastatic | 3 0.03 39.41 Lung carcinoma cell type unspecified .. | 2 0.02 39.43 Lung disorder | 6 0.06 39.49 Lung infection | 5 0.05 39.54 Lung neoplasm malignant | 5 0.05 39.59 Lung transplant | 1 0.01 39.60 Lupus nephritis | 20 0.20 39.80 Lyme disease | 1 0.01 39.81 Lymphoma | 10 0.10 39.91 Macular degeneration | 2 0.02 39.93 Major depression | 2 0.02 39.95 Malaria prophylaxis | 1 0.01 39.96 Malignant hydatidiform mole | 1 0.01 39.97 Malignant hypertension | 1 0.01 39.98 Malignant melanoma | 4 0.04 40.02 Malignant peritoneal neoplasm | 4 0.04 40.06 Malignant pituitary tumour | 1 0.01 40.07 Mania | 1 0.01 40.08 Mantle cell lymphoma | 12 0.12 40.20 Mastocytosis | 1 0.01 40.21 Mastoiditis | 5 0.05 40.26 Maternal exposure timing unspecified | 7 0.07 40.33 Meniere's disease | 1 0.01 40.34 Menopausal symptoms | 2 0.02 40.36 Menstruation irregular | 1 0.01 40.37 Mental disorder | 8 0.08 40.45 Metabolic syndrome | 4 0.04 40.49 Metastases to adrenals | 1 0.01 40.50 Metastases to bone | 44 0.44 40.94 Metastases to central nervous system | 1 0.01 40.95 Metastases to liver | 6 0.06 41.01 Metastases to lung | 1 0.01 41.02 Metastases to lymph nodes | 1 0.01 41.03 Metastases to ovary | 1 0.01 41.04 Metastases to spine | 1 0.01 41.05 Metastatic carcinoid tumour | 1 0.01 41.06 Metastatic renal cell carcinoma | 6 0.06 41.12 Micturition disorder | 1 0.01 41.13 Migraine | 21 0.21 41.34 Mineral supplementation | 5 0.05 41.39 Mononeuritis | 1 0.01 41.40 Mood altered | 1 0.01 41.41 Mood swings | 1 0.01 41.42 Mouth ulceration | 2 0.02 41.44 Muckle-Wells syndrome | 2 0.02 41.46 Mucopolysaccharidosis I | 1 0.01 41.47 Mucopolysaccharidosis II | 1 0.01 41.48 Mucopolysaccharidosis VI | 4 0.04 41.52 Mucosal inflammation | 3 0.03 41.55 Multiple sclerosis | 129 1.29 42.84 Multiple sclerosis relapse | 3 0.03 42.87 Muscle mass | 2 0.02 42.89 Muscle relaxant therapy | 5 0.05 42.94 Muscle spasms | 9 0.09 43.03 Muscle spasticity | 1 0.01 43.04 Musculoskeletal chest pain | 1 0.01 43.05 Musculoskeletal pain | 3 0.03 43.08 Myalgia | 8 0.08 43.16 Mycobacterium marinum infection | 5 0.05 43.21 Myelodysplastic syndrome | 10 0.10 43.31 Myelofibrosis | 21 0.21 43.52 Myeloid leukaemia | 1 0.01 43.53 Myeloproliferative neoplasm | 2 0.02 43.55 Myocardial infarction | 12 0.12 43.67 Myocardial ischaemia | 7 0.07 43.74 Narcolepsy | 13 0.13 43.87 Nasal congestion | 1 0.01 43.88 Nasopharyngitis | 18 0.18 44.06 Nausea | 23 0.23 44.29 Neck pain | 10 0.10 44.39 Neoplasm malignant | 3 0.03 44.42 Neovascular age-related macular degen.. | 3 0.03 44.45 Nephrogenic anaemia | 5 0.05 44.50 Nephrolithiasis | 2 0.02 44.52 Nephropathy | 1 0.01 44.53 Nephrotic syndrome | 7 0.07 44.60 Nerve compression | 4 0.04 44.64 Nerve injury | 8 0.08 44.72 Nervous system disorder | 2 0.02 44.74 Nervousness | 1 0.01 44.75 Neuralgia | 31 0.31 45.06 Neuritis | 1 0.01 45.07 Neuroendocrine carcinoma | 1 0.01 45.08 Neuroendocrine carcinoma metastatic | 2 0.02 45.10 Neuroendocrine carcinoma of the skin | 4 0.04 45.14 Neuroendocrine tumour | 4 0.04 45.18 Neurogenic bladder | 1 0.01 45.19 Neuromyelitis optica spectrum disorder | 2 0.02 45.21 Neuropathy peripheral | 51 0.51 45.72 Neutropenia | 2 0.02 45.74 Neutropenic sepsis | 2 0.02 45.76 Neutrophil count decreased | 1 0.01 45.77 Night sweats | 1 0.01 45.78 Nightmare | 1 0.01 45.79 Nocturia | 2 0.02 45.81 Non-Hodgkin's lymphoma | 6 0.06 45.87 Non-small cell lung cancer | 6 0.06 45.93 Nuclear magnetic resonance imaging | 4 0.04 45.97 Nuclear magnetic resonance imaging br.. | 1 0.01 45.98 Nuclear magnetic resonance imaging he.. | 1 0.01 45.99 Nutritional supplementation | 3 0.03 46.02 Nystagmus | 1 0.01 46.03 Obesity | 1 0.01 46.04 Obsessive-compulsive disorder | 11 0.11 46.15 Oedema | 16 0.16 46.31 Oedema due to hepatic disease | 1 0.01 46.32 Oedema peripheral | 5 0.05 46.37 Oesophageal candidiasis | 1 0.01 46.38 Oesophagitis | 1 0.01 46.39 Off label use | 8 0.08 46.47 Open angle glaucoma | 2 0.02 46.49 Opportunistic infection prophylaxis | 1 0.01 46.50 Oral candidiasis | 1 0.01 46.51 Oral contraception | 1 0.01 46.52 Oral fungal infection | 1 0.01 46.53 Oral lichen planus | 1 0.01 46.54 Oral pain | 1 0.01 46.55 Oropharyngeal pain | 2 0.02 46.57 Osteitis | 4 0.04 46.61 Osteitis deformans | 2 0.02 46.63 Osteoarthritis | 5 0.05 46.68 Osteomyelitis | 3 0.03 46.71 Osteopenia | 19 0.19 46.90 Osteoporosis | 76 0.76 47.66 Osteoporosis prophylaxis | 3 0.03 47.69 Osteoporotic fracture | 3 0.03 47.72 Ovarian cancer | 19 0.19 47.91 Ovarian cancer recurrent | 3 0.03 47.94 Ovarian cyst | 2 0.02 47.96 POEMS syndrome | 2 0.02 47.98 Pain | 153 1.53 49.51 Pain in extremity | 8 0.08 49.59 Pain management | 3 0.03 49.62 Pain prophylaxis | 2 0.02 49.64 Palpitations | 1 0.01 49.65 Pancreas transplant | 1 0.01 49.66 Pancreas transplant rejection | 1 0.01 49.67 Pancreatic carcinoma | 3 0.03 49.70 Pancreatic carcinoma metastatic | 6 0.06 49.76 Pancreatic enzymes increased | 1 0.01 49.77 Pancreatic failure | 2 0.02 49.79 Pancreatic neuroendocrine tumour | 3 0.03 49.82 Pancreatic neuroendocrine tumour meta.. | 1 0.01 49.83 Panic attack | 3 0.03 49.86 Panic disorder | 7 0.07 49.93 Papillary thyroid cancer | 3 0.03 49.96 Paraesthesia | 7 0.07 50.03 Paranoia | 2 0.02 50.05 Parkinson's disease | 50 0.50 50.55 Paroxysmal nocturnal haemoglobinuria | 9 0.09 50.64 Partial seizures | 3 0.03 50.67 Partial seizures with secondary gener.. | 1 0.01 50.68 Pelvic pain | 9 0.09 50.77 Pemphigoid | 5 0.05 50.82 Pemphigus | 5 0.05 50.87 Peptic ulcer | 2 0.02 50.89 Periarthritis | 1 0.01 50.90 Perinatal depression | 5 0.05 50.95 Peripheral artery stenosis | 2 0.02 50.97 Peripheral artery thrombosis | 7 0.07 51.04 Peripheral vascular disorder | 2 0.02 51.06 Pernicious anaemia | 2 0.02 51.08 Peroneal nerve injury | 1 0.01 51.09 Personality disorder | 2 0.02 51.11 Phantom pain | 1 0.01 51.12 Pharyngitis | 9 0.09 51.21 Pharyngitis streptococcal | 1 0.01 51.22 Photodynamic therapy | 1 0.01 51.23 Pituitary cyst | 1 0.01 51.24 Pituitary tumour | 1 0.01 51.25 Plasma cell myeloma | 44 0.44 51.69 Plasma cell myeloma recurrent | 1 0.01 51.70 Pleural effusion | 2 0.02 51.72 Pneumocystis jirovecii infection | 1 0.01 51.73 Pneumocystis jirovecii pneumonia | 5 0.05 51.78 Pneumonia | 13 0.13 51.91 Pneumonia aspiration | 2 0.02 51.93 Pneumonia bacterial | 2 0.02 51.95 Pneumonia legionella | 8 0.08 52.03 Pneumonia pseudomonal | 1 0.01 52.04 Pollakiuria | 1 0.01 52.05 Polyarthritis | 1 0.01 52.06 Polycythaemia vera | 1 0.01 52.07 Polyneuropathy | 5 0.05 52.12 Polyuria | 3 0.03 52.15 Portal hypertension | 2 0.02 52.17 Post coital contraception | 231 2.31 54.48 Post herpetic neuralgia | 4 0.04 54.52 Post procedural complication | 1 0.01 54.53 Post-traumatic stress disorder | 9 0.09 54.62 Pregnancy | 8 0.08 54.70 Premedication | 70 0.70 55.40 Premenstrual syndrome | 1 0.01 55.41 Presyncope | 1 0.01 55.42 Primary insulin like growth factor-1 .. | 2 0.02 55.44 Primary mediastinal large B-cell lymp.. | 6 0.06 55.50 Primary myelofibrosis | 2 0.02 55.52 Procedural pain | 1 0.01 55.53 Product administration error | 2 0.02 55.55 Product use in unapproved indication | 2 0.02 55.57 Product used for unknown indication | 2,947 29.47 85.04 Productive cough | 1 0.01 85.05 Prolactin-producing pituitary tumour | 1 0.01 85.06 Promotion of peripheral circulation | 1 0.01 85.07 Prophylaxis | 236 2.36 87.43 Prophylaxis against diarrhoea | 1 0.01 87.44 Prophylaxis against gastrointestinal .. | 7 0.07 87.51 Prophylaxis against graft versus host.. | 5 0.05 87.56 Prophylaxis against transplant reject.. | 13 0.13 87.69 Prophylaxis of neural tube defect | 2 0.02 87.71 Prostate cancer | 34 0.34 88.05 Prostate cancer metastatic | 30 0.30 88.35 Prostatomegaly | 2 0.02 88.37 Proteinuria | 3 0.03 88.40 Pruritus | 4 0.04 88.44 Psoriasis | 43 0.43 88.87 Psoriatic arthropathy | 42 0.42 89.29 Psychiatric decompensation | 2 0.02 89.31 Psychotic disorder | 26 0.26 89.57 Psychotic symptom | 2 0.02 89.59 Pulmonary arterial hypertension | 38 0.38 89.97 Pulmonary artery therapeutic procedure | 3 0.03 90.00 Pulmonary embolism | 7 0.07 90.07 Pulmonary fibrosis | 1 0.01 90.08 Pulmonary hypertension | 28 0.28 90.36 Pulmonary mycosis | 1 0.01 90.37 Pyelonephritis | 1 0.01 90.38 Pyrexia | 15 0.15 90.53 Radiculopathy | 2 0.02 90.55 Rash | 9 0.09 90.64 Rash generalised | 2 0.02 90.66 Rectal adenocarcinoma | 1 0.01 90.67 Rectal cancer | 8 0.08 90.75 Rectal cancer metastatic | 3 0.03 90.78 Refractory cytopenia with unilineage .. | 1 0.01 90.79 Relapsing-remitting multiple sclerosis | 11 0.11 90.90 Relaxation therapy | 2 0.02 90.92 Renal cancer | 1 0.01 90.93 Renal cancer metastatic | 1 0.01 90.94 Renal cell carcinoma | 3 0.03 90.97 Renal disorder | 8 0.08 91.05 Renal failure | 8 0.08 91.13 Renal impairment | 1 0.01 91.14 Renal transplant | 14 0.14 91.28 Respiratory disorder | 2 0.02 91.30 Respiratory failure | 1 0.01 91.31 Respiratory tract congestion | 2 0.02 91.33 Respiratory tract infection | 4 0.04 91.37 Restless legs syndrome | 6 0.06 91.43 Rheumatoid arthritis | 208 2.08 93.51 Rhinitis | 5 0.05 93.56 Rhinitis allergic | 3 0.03 93.59 Rhinitis perennial | 3 0.03 93.62 Right ventricular dysfunction | 1 0.01 93.63 Right ventricular failure | 5 0.05 93.68 Rosacea | 2 0.02 93.70 Rotator cuff syndrome | 1 0.01 93.71 Routine health maintenance | 3 0.03 93.74 Sarcoidosis | 1 0.01 93.75 Sarcoma metastatic | 2 0.02 93.77 Scan with contrast | 1 0.01 93.78 Schizoaffective disorder | 3 0.03 93.81 Schizophrenia | 10 0.10 93.91 Scleroderma | 2 0.02 93.93 Seasonal affective disorder | 1 0.01 93.94 Seasonal allergy | 7 0.07 94.01 Seborrhoeic dermatitis | 1 0.01 94.02 Secondary hypertension | 3 0.03 94.05 Secondary progressive multiple sclero.. | 1 0.01 94.06 Secretion discharge | 1 0.01 94.07 Sedation | 3 0.03 94.10 Sedative therapy | 1 0.01 94.11 Seizure | 17 0.17 94.28 Seizure prophylaxis | 2 0.02 94.30 Self-medication | 4 0.04 94.34 Sensation of blood flow | 1 0.01 94.35 Sepsis | 11 0.11 94.46 Septic shock | 2 0.02 94.48 Shift work disorder | 1 0.01 94.49 Sinus disorder | 5 0.05 94.54 Sinusitis | 19 0.19 94.73 Skin infection | 1 0.01 94.74 Sleep disorder | 45 0.45 95.19 Sleep disorder therapy | 2 0.02 95.21 Small cell lung cancer | 8 0.08 95.29 Smoking cessation therapy | 9 0.09 95.38 Somnolence | 1 0.01 95.39 Spinal column stenosis | 3 0.03 95.42 Spinal compression fracture | 1 0.01 95.43 Spinal osteoarthritis | 6 0.06 95.49 Spinal pain | 1 0.01 95.50 Splenic infarction | 2 0.02 95.52 Spondylitis | 7 0.07 95.59 Sputum purulent | 1 0.01 95.60 Squamous cell carcinoma | 3 0.03 95.63 Squamous cell carcinoma of head and n.. | 3 0.03 95.66 Squamous cell carcinoma of the cervix | 2 0.02 95.68 Status epilepticus | 17 0.17 95.85 Stem cell transplant | 3 0.03 95.88 Stent placement | 2 0.02 95.90 Steroid therapy | 1 0.01 95.91 Still's disease | 9 0.09 96.00 Stomatitis | 4 0.04 96.04 Stress | 4 0.04 96.08 Stroke volume decreased | 1 0.01 96.09 Substance use | 1 0.01 96.10 Suicide attempt | 13 0.13 96.23 Supplementation therapy | 10 0.10 96.33 Systemic candida | 2 0.02 96.35 Systemic lupus erythematosus | 20 0.20 96.55 Systemic mastocytosis | 1 0.01 96.56 Systemic scleroderma | 1 0.01 96.57 T-cell prolymphocytic leukaemia | 1 0.01 96.58 Tachycardia | 14 0.14 96.72 Tardive dyskinesia | 1 0.01 96.73 Telangiectasia | 1 0.01 96.74 Testicular seminoma (pure) | 3 0.03 96.77 Thalassaemia beta | 1 0.01 96.78 Therapeutic response shortened | 4 0.04 96.82 Thrombosis | 6 0.06 96.88 Thrombosis prophylaxis | 27 0.27 97.15 Thymoma | 1 0.01 97.16 Thyroid cancer | 2 0.02 97.18 Thyroid disorder | 14 0.14 97.32 Tinnitus | 3 0.03 97.35 Tobacco user | 1 0.01 97.36 Tocolysis | 1 0.01 97.37 Tooth abscess | 1 0.01 97.38 Tooth extraction | 2 0.02 97.40 Transitional cell carcinoma | 4 0.04 97.44 Transplant | 6 0.06 97.50 Tremor | 4 0.04 97.54 Trigeminal neuralgia | 2 0.02 97.56 Tuberculosis | 7 0.07 97.63 Type 1 diabetes mellitus | 12 0.12 97.75 Type 2 diabetes mellitus | 102 1.02 98.77 Typhoid fever | 1 0.01 98.78 Ulcer | 2 0.02 98.80 Ulcer haemorrhage | 1 0.01 98.81 Unevaluable therapy | 9 0.09 98.90 Unrelated donor bone marrow transplan.. | 1 0.01 98.91 Upper gastrointestinal haemorrhage | 1 0.01 98.92 Upper respiratory tract infection | 1 0.01 98.93 Upper respiratory tract inflammation | 7 0.07 99.00 Urge incontinence | 1 0.01 99.01 Urinary incontinence | 3 0.03 99.04 Urinary retention | 1 0.01 99.05 Urinary tract disorder | 4 0.04 99.09 Urinary tract infection | 6 0.06 99.15 Urticaria chronic | 2 0.02 99.17 Varices oesophageal | 2 0.02 99.19 Vascular dementia | 4 0.04 99.23 Vasculitis | 1 0.01 99.24 Vein disorder | 2 0.02 99.26 Vena cava thrombosis | 5 0.05 99.31 Venous occlusion | 3 0.03 99.34 Ventricular extrasystoles | 1 0.01 99.35 Vertebroplasty | 4 0.04 99.39 Vertigo | 3 0.03 99.42 Viral hepatitis carrier | 2 0.02 99.44 Viral infection | 1 0.01 99.45 Visual acuity reduced | 1 0.01 99.46 Vitamin B12 | 1 0.01 99.47 Vitamin B12 deficiency | 3 0.03 99.50 Vitamin D deficiency | 7 0.07 99.57 Vitamin supplementation | 18 0.18 99.75 Vomiting | 8 0.08 99.83 Vulvovaginal candidiasis | 3 0.03 99.86 Weight control | 1 0.01 99.87 Weight decreased | 2 0.02 99.89 Wheezing | 1 0.01 99.90 Whipple's disease | 6 0.06 99.96 White blood cell count decreased | 1 0.01 99.97 Wound infection | 1 0.01 99.98 Wound treatment | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 7 Mar 2019